header CGT report 540x680@2x

Cell & Gene Therapy:
2023 Market Analysis, CDMO Pricing and Competitor Benchmarking

Published August, 2023
  • 230 pages of Cell & Gene Therapy market analysis
  • 2023 pricing comparison for broad CDMO services
  • Market intelligence for viral vector and plasmid DNA manufacture
  • 94 unique Cell & Gene Therapy CDMO profiles
  • Benchmarking of top CDMOs’ proprietary technologies
  • Scientific insights from PhDs, CDMO owners and researchers
header CGT report 540x680@2x

Key market insights for innovators, CDMOs and investors in the Cell & Gene Therapy industry.

01 analysis icon 65x65@2x

Scientific analysis on ATMPs — The New Frontier

Stay up to date with market trends for Cell and Gene Therapies straight from the industry’s KOLs. Our Market Analysis gains insights from CDMO owners, PhDs and researchers across advanced therapeutics. Measure your business against your peers using our robust analysis of AAV, lentiviral and plasmid DNA manufacture.

02 benchmarking icon 65x65@2x

Exclusive CDMO pricing data for benchmarking

Our pricing matrix uses data from across the industry so you can make informed decisions for your business. Compare your prices over time against your peers in respect to material costs, infrastructure and development process.

Published August, 2023

Unequaled price benchmarking and market intelligence for Cell & Gene Therapy manufacturing — all in one report.

The Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking provides

01 pricing data icon 65x65@2x
Current pricing data for manufacturing across advanced Cell & Gene Therapies
02 profiles icon 65x65@2x
94 significant CDMO profiles including capabilities, capacity, proprietary technologies and locations
03 scientific analysis icon 65x65@2x
Scientific analysis of the manufacturing process for AAV, lentivirus and plasmid DNA
04 supply chain challenges icon 65x65@2x
Unique supply chain challenges and the shift from supply chain to value chain management
05 investment outlook icon 65x65@2x
Investment outlook into new modalities — analyzing economic temperature and regulatory conditions
06 innovations icon 65x65@2x
Innovations and breakthroughs that are invaluable to the next generation of therapies

Over 1000 hours of data collection and analysis
from interviews, primary research and progressive study

CGT report form 606x630
Published August, 2023
Request a quote for the 2023 Cell & Gene Therapy Report

CGT report form 606x630